Dr. Bradford Wilson is the Co-Founder and Chief Scientific Officer for IndyGeneUS AI. IndyGeneUS is a genomics company creating the world’s largest block-chain encrypted repository of indigenous, African, and diasporic African clinical and genomic data for disease prevention and detection, drug discovery and development, clinical disease management, and precision health equity.
As CSO, Dr. Wilson leads the research agenda, STEM education and training efforts, and contributes to the development strategic partnerships and investor relations.
Based in Charlotte, North Carolina, Dr. Wilson is a geneticist by training with over fifteen years of health disparities research and genetic sequencing experience. Dr. Wilson has peer-reviewed publications on breast and prostate cancer, and cancer prevention. Pharmacogenomics (PGx) and health policy in Africa and PGx in opioid use disorder are the subject matter of additional coauthored manuscripts. Dr. Wilson has spent the past five years building and developing biotech startup companies which leverage genomics and utilize next-generation (NGS) technology including two from the seventh cycle of the illumina Accelerator.
As a biotech startup entrepreneur, Dr. Wilson developed an NGS-based, 775 amplicon gene expression assay for predisposition to conditions including anxiety, bipolar disorder, depression, and post-traumatic stress disorder (PTSD). He also directed the development of a direct-to-consumer genetic test assessing factors affecting fertility including nutrigenomics or the genetics of nutrient metabolism, wellness traits including insulin resistance, and variants associated with polycystic ovary syndrome (PCOS).
Dr. Wilson is a investigator dedicated to leveraging genomics towards the elimination of health disparities disproportionately affecting underrepresented and underserved populations in the areas of cancer, cardiometabolic & cardiovascular diseases, infectious and immune diseases, mental health, and women's and reproductive health. He was recently invited to join the advisory board of The White Dress Project, a uterine fibroid advocacy organization for Black women headquartered in Atlanta, GA.
As an educator, he has instructed undergraduate, graduate, and professional students in biology and genetics courses at Howard University and Johnson C. Smith University. Dr. Wilson created a course entitled "Genomics in Society" which discussed the multiplicity of ways genomics is currently integrated into human life from agriculture and ancestry to carrier, prenatal, and newborn screening, and cancer diagnosis. He has also trained numerous students in nucleic acid extraction as well as sequencing across multiple platforms.
Dr. Wilson received his bachelor’s degree in Biology and his master’s and doctoral degrees in Genetics and Human Genetics from Howard University. Dr. Wilson’s graduate research focused on prostate cancer and he has co-authored peer-reviewed manuscripts on breast and prostate cancer as well as pharmacogenomics policy and utilization in medication assisted treatment (MAT) for opioid use disorder (OUD).
Born in Brooklyn and raised in Jamaica Queens where he earned entry into one of New York City's three specialized high schools, earned a Regent's diploma and was a National Merit Scholarship recipient. Dr. Wilson’s family hails from Florence, SC and St. Thomas, Jamaica WI. Through his work with African Ancestry.com, his maternal and paternal ancestry was traced to the Mandinka tribe in Senegal and the Bamileke tribe in Cameroon respectively, connecting him to multiple populations across the African diaspora. Dr. Wilson has had the opportunity and privilege to travel to the African continent on two occasions where he visited Senegal, The Gambia, and Egypt and looks forward to the opportunity to return.
Brad is active on LinkedIn and manages content that the company shares on this platform. Connect with him today on LinkedIn!